These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26730498)

  • 1. Treatment of infertility and the risk of ovarian cancer: are the data reassuring?
    Paulson RJ
    Fertil Steril; 2016 Mar; 105(3):605-606. PubMed ID: 26730498
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
    Gronwald J; Glass K; Rosen B; Karlan B; Tung N; Neuhausen SL; Moller P; Ainsworth P; Sun P; Narod SA; Lubinski J; Kotsopoulos J;
    Fertil Steril; 2016 Mar; 105(3):781-785. PubMed ID: 26698676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and BRCA2 mutation type associated with cancer risk.
    Burki TK
    Lancet Oncol; 2015 May; 16(5):e205. PubMed ID: 25892146
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Kotsopoulos J; Lubinski J; Gronwald J; Cybulski C; Demsky R; Neuhausen SL; Kim-Sing C; Tung N; Friedman S; Senter L; Weitzel J; Karlan B; Moller P; Sun P; Narod SA;
    Int J Cancer; 2015 Sep; 137(5):1136-46. PubMed ID: 25482078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
    McLaughlin JR; Risch HA; Lubinski J; Moller P; Ghadirian P; Lynch H; Karlan B; Fishman D; Rosen B; Neuhausen SL; Offit K; Kauff N; Domchek S; Tung N; Friedman E; Foulkes W; Sun P; Narod SA;
    Lancet Oncol; 2007 Jan; 8(1):26-34. PubMed ID: 17196508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
    van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
    Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness analysis of genetic testing for breast and ovarian cancer susceptibility genes: BRCA1 and BRCA2.
    Kaldate R; Huston A; McCoy H; Cardeiro D; Noyes K
    Breast J; 2014; 20(3):325-6. PubMed ID: 24708220
    [No Abstract]   [Full Text] [Related]  

  • 8. Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.
    Kotsopoulos J; Gronwald J; Karlan B; Rosen B; Huzarski T; Moller P; Lynch HT; Singer CF; Senter L; Neuhausen SL; Tung N; Eisen A; Foulkes WD; Ainsworth P; Sun P; Lubinski J; Narod SA;
    Gynecol Oncol; 2018 Jul; 150(1):85-91. PubMed ID: 29793803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reflections on treatments for infertility and the possible occurrence of ovarian carcinomas.].
    Ferranti G; Prosperi Porta R; La Rosa VL; Vitale SG; Laganà AS
    Recenti Prog Med; 2017 Mar; 108(3):136-140. PubMed ID: 28398407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of BRCA1/2 on Ovarian and Breast Cancer Survival--Response.
    Zhong Q; Peng HL; Zhao X; Zhang L; Hwang WT
    Clin Cancer Res; 2015 Aug; 21(16):3807. PubMed ID: 26275954
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of BRCA1/2 on Ovarian and Breast Cancer Survival--Letter.
    Gong L; Dong C; Ouyang W
    Clin Cancer Res; 2015 Aug; 21(16):3806. PubMed ID: 26275953
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
    Meyer P; Voigtlaender T; Bartram CR; Klaes R
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is It time to stratify for BRCA mutation status in therapeutic trials in ovarian cancer?
    Kauff ND
    J Clin Oncol; 2008 Jan; 26(1):9-10. PubMed ID: 18165631
    [No Abstract]   [Full Text] [Related]  

  • 15. Biology of hereditary breast and ovarian cancers.
    Tommasi S
    Ann Oncol; 2013 Nov; 24 Suppl 8():viii7. PubMed ID: 24131975
    [No Abstract]   [Full Text] [Related]  

  • 16. BRCA-related ovarian carcinoma.
    Rubin SC
    Cancer; 2003 May; 97(9):2127-9. PubMed ID: 12712461
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
    Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
    Zhong Q; Peng HL; Zhao X; Zhang L; Hwang WT
    Clin Cancer Res; 2015 Jan; 21(1):211-20. PubMed ID: 25348513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.
    Hanley GE; McAlpine JN; Miller D; Huntsman D; Schrader KA; Blake Gilks C; Mitchell G
    BMC Cancer; 2018 Mar; 18(1):254. PubMed ID: 29506471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.
    Riahi A; Kharrat M; Ghourabi ME; Khomsi F; Gamoudi A; Lariani I; May AE; Rahal K; Chaabouni-Bouhamed H
    Clin Genet; 2015 Feb; 87(2):155-60. PubMed ID: 24372583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.